Omission of Radiotherapy in Primary Mediastinal B-Cell Lymphoma: IELSG37 Trial ResultsMaurizio Martelli, Luca Ceriani, Giovannino Ciccone et al.|Journal of Clinical Oncology|2024Cited by 30
A comprehensive genetic study of classic Hodgkin lymphoma using circulating tumor DNAMaria Cristina Pirosa, Luca Ceriani, Stéphane Chauvie et al.|Blood|2025Cited by 19
Dose-dense ABVD as first-line therapy in early-stage unfavorable Hodgkin lymphoma: results of a prospective, multicenter double-step phase II study by Fondazione Italiana LinfomiArmando Santoro, Francesco Merli, Rita Mazza et al.|Annals of Hematology|2021Cited by 2
S225: CIRCULATING TUMOR DNA IS A PROGNOSTIC BIOMARKER AT BASELINE AND IMPROVES THE ACCURACY OF INTERIM PET IN CLASSIC HODGKIN LYMPHOMAMaria Cristina Pirosa, Davide Rossi, Alessio Bruscaggin et al.|HemaSphere|2022Cited by 1
Non-Coding Mutations of <i>BCL6</i> in Classical Hodgkin LymphomaMaria Cristina Pirosa, Davide Rossi, Matin Salehi et al.|Blood|2024Cited by 1